PRASCEND is the first and only medicine available in the US that is fully approved by the FDA to treat pituitary pars intermedia
dysfunction. The first licensed medicine for the treatment of clinical signs associated with PPID in horses (equine Cushing’s
disease).

• (Loading SDS PDF)  SDS Sheet